– Second-Quarter Revenue of $973.1 Million – – Second-Quarter GAAP Earnings per Share of $2.13 and Non-GAAP Earnings per Share of $2.77 – – Reduces 2022 Guidance – WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #CRL–Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2022. For the quarter, revenue was $973.1 million, … [Read more…]
LONDON–(BUSINESS WIRE)–#advancedcirculatorysupport–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2022. Financial Summary and Highlights1 Revenue of $254.2 million for the quarter, decreased 3.9 percent on a reported basis and increased 0.5 percent on a constant-currency basis, as compared to the prior-year period Revenue, … [Read more…]
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended June 30, 2022. Total revenues in the second quarter of 2022 grew 5% year-over-year to $466.9 million, compared to $446.5 million in the second quarter of 2021. “I’m extraordinarily … [Read more…]
BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst—Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will present at the Canaccord Genuity 42nd Annual Growth Conference being held August 8-11, 2022. Canaccord Genuity 42nd Annual Growth Conference Date: Wednesday, August 10, 2022 Time: … [Read more…]
Nationally Recognized Fundraising Trailblazer Brittany N. Shaff to Spearhead SFG to Provide Personalized, Digital Approach to Nonprofit, Education, and Healthcare Fundraising and Engagement for Sustainable Philanthropic Growth BALTIMORE–(BUSINESS WIRE)–Shaff Fundraising Group (SFG) announced today its launch to provide strategic philanthropy and engagement management consulting. Partnering with nonprofits, independent schools, higher education, and healthcare organizations, SFG … [Read more…]
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that based on related clinical trials and studies of vaccination for local children and adolescents, the Health Bureau of the Government of the Hong Kong Special Administrative Region of the People’s Republic of China has approved … [Read more…]
SAN DIEGO–(BUSINESS WIRE)–Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, today released a statement regarding results of a jury trial in the patent litigation brought by Magnolia Medical Technologies. Magnolia Medical originally asserted four patents in the case. By the time of the trial, all of these patents were dropped, … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Neonatal Care Devices Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. The neonatal care industry is shifting its focus to providing family-centric and developmental care to neonates. Neonatal Intensive Care Units (NICUs) are looking at reducing neonatal stress, such as noise and intense light, to provide complete holistic care for neonates. … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Biotechnology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global biotechnology market reached a value of US$ 617.98 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 964.96 Billion by 2027, exhibiting a CAGR of … [Read more…]
At the primary analysis, the trial did not meet its primary endpoint of overall survival (OS) The safety profile was consistent with previously reported studies of Onivyde® (irinotecan liposomal injection) The clinical study results will be communicated with the regulatory agency PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Phase III … [Read more…]
